BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 33213798)

  • 1. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
    Kamboj AK; Katzka DA; Iyer PG
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and surveillance for complications related to gastroesophageal reflux disease.
    Spechler SJ
    Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who Deserves Endoscopic Screening for Esophageal Neoplasia?
    Blevins CH; Iyer PG
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):365-378. PubMed ID: 28577762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance in Barrett's esophagus: an audit of practice.
    Ajumobi A; Bahjri K; Jackson C; Griffin R
    Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and surveillance in Barrett's esophagus: a call to action.
    Eisen GM; Lieberman D; Fennerty MB; Sonnenberg A
    Clin Gastroenterol Hepatol; 2004 Oct; 2(10):861-4. PubMed ID: 15476148
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening and surveillance of Barrett's esophagus.
    Michalak J; Bansal A; Sharma P
    Curr Gastroenterol Rep; 2009 Jun; 11(3):195-201. PubMed ID: 19463219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best Practices in Surveillance for Barrett's Esophagus.
    Triggs JR; Falk GW
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):59-75. PubMed ID: 33213800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Screening Tests for Barrett's Esophagus.
    Codipilly DC; Iyer PG
    Curr Gastroenterol Rep; 2019 Jul; 21(9):42. PubMed ID: 31346777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management.
    Dent J
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():11-30. PubMed ID: 21199510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Barrett's esophagus: screening and prognosis].
    Mazzucchelli L; Wagner AC
    Ther Umsch; 2001 Mar; 58(3):158-64. PubMed ID: 11305154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of young patients with early Barrett's neoplasia.
    Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
    World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus, towards improved clinical practice.
    Martínez-Domínguez SJ; Lanas Á; Domper-Arnal MJ
    Med Clin (Barc); 2022 Jul; 159(2):92-100. PubMed ID: 35606193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease.
    Gerson LB; Groeneveld PW; Triadafilopoulos G
    Clin Gastroenterol Hepatol; 2004 Oct; 2(10):868-79. PubMed ID: 15476150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Risk in Barrett's Esophagus: A Clinical Review.
    Beydoun AS; Stabenau KA; Altman KW; Johnston N
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal adenocarcinoma and Barrett's esophagus.
    Sayana H; Wani S; Sharma P
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):157-69. PubMed ID: 17557044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are screening and surveillance for Barrett's oesophagus really worthwhile?
    Sharma P; Sidorenko EI
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
    Sostres C; Lacarta P; Lanas A
    Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.